MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
Insider trades, last 90 days
1 buy · 2 sells
- Bought $6.63K
- Sold $82.07K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
78
- +2 vs. Q1 2026
- Total value $85.53M
Superinvestors holding MDWD
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MDWD insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 20264:02 PM ET | Sep 1, 2026 | Rubinstein SamuelDirector | SSaleOrdinary Shares | −525 | $12.72 | −$6.68K | 0 | −100.0% | SEC |
| Sep 2, 20264:02 PM ET | Sep 1, 2026 | Rubinstein SamuelDirector | PPurchaseOrdinary Shares | +525 | $12.62 | +$6.63K | 525 | New position | SEC |
| Aug 28, 20264:02 PM ET | Aug 26 – Aug 27, 2026 | Hess ShmuelCOO & Chief Commercial Officer | SSaleOrdinary Shares | −5.82K | $12.9477 | −$75.39K | 0 | −100.0% | SEC |
| Jun 4, 2026 | Jun 3, 2026 | SHAMIR NACHUMDirector | PPurchaseOrdinary Shares | +6K | $13.9994 | +$84K | 55.82K | +12.0% | SEC |
| Jun 2, 2026 | Jun 1, 2026 | Fox David MortonDirector | PPurchaseOrdinary Shares | +3.54K | $14.1131 | +$49.92K | 22.28K | +18.9% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MDWD at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| INVESTOR AB | 872,093 | $12.82M | 0.09% | 00.0% | Unchanged |
| Yelin Lapidot Holdings Management Ltd. | 758,169 | $11.15M | 2.11% | −4,648−0.6% | Reduced |
| Rosalind Advisors, Inc. | 749,054 | $11.01M | 4.14% | 00.0% | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ | 641,075 | $9.43M | 0.00% | −68,772−9.7% | Reduced |
| BlackRock, Inc. | 525,929 | $7.73M | 0.00% | +80,095+18.0% | Added |